Literature DB >> 24709843

Transplantation. T-cell depletion--balancing acute rejection and cancer risk.

Uttam G Reddy1, Gabriel M Danovitch1.   

Abstract

The authors of a new study suggest that the proinflammatory state of acute rejection combined with the use of T-cell-depleting antibody therapy might explain the increased risk of cancer after kidney transplantation. However, their findings do not fully support this conclusion; use of T-cell-depleting antibodies alone is likely to increase cancer risk.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24709843     DOI： 10.1038/nrneph.2014.61

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


  10 in total

Review 1.  Skin cancers after organ transplantation.

Authors:  Sylvie Euvrard; Jean Kanitakis; Alain Claudy
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

2.  Cancer incidence before and after kidney transplantation.

Authors:  Claire M Vajdic; Stephen P McDonald; Margaret R E McCredie; Marina T van Leeuwen; John H Stewart; Matthew Law; Jeremy R Chapman; Angela C Webster; John M Kaldor; Andrew E Grulich
Journal:  JAMA       Date:  2006-12-20       Impact factor: 56.272

Review 3.  Inflammatory chemokines and metastasis--tracing the accessory.

Authors:  L Borsig; M J Wolf; M Roblek; A Lorentzen; M Heikenwalder
Journal:  Oncogene       Date:  2013-07-15       Impact factor: 9.867

4.  Skin cancer in heart transplant recipients: risk factor analysis and relevance of immunosuppressive therapy.

Authors:  A L Caforio; A B Fortina; S Piaserico; M Alaibac; F Tona; G Feltrin; E Pompei; L Testolin; A Gambino; S D Volta; G Thiene; D Casarotto; A Peserico
Journal:  Circulation       Date:  2000-11-07       Impact factor: 29.690

5.  Acute rejection, T-cell-depleting antibodies, and cancer after transplantation.

Authors:  Wai H Lim; Robin M Turner; Jeremy R Chapman; Maggie K M Ma; Angela C Webster; Jonathan C Craig; Germaine Wong
Journal:  Transplantation       Date:  2014-04-27       Impact factor: 4.939

6.  Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation.

Authors:  Marina T van Leeuwen; Andrew E Grulich; Angela C Webster; Margaret R E McCredie; John H Stewart; Stephen P McDonald; Janaki Amin; John M Kaldor; Jeremy R Chapman; Claire M Vajdic
Journal:  Blood       Date:  2009-05-14       Impact factor: 22.113

7.  Cancer after kidney transplantation in the United States.

Authors:  Bertram L Kasiske; Jon J Snyder; David T Gilbertson; Changchun Wang
Journal:  Am J Transplant       Date:  2004-06       Impact factor: 8.086

Review 8.  Interleukin 2 receptor antagonists for kidney transplant recipients.

Authors:  Angela C Webster; Lorenn P Ruster; Richard McGee; Sandra L Matheson; Gail Y Higgins; Narelle S Willis; Jeremy R Chapman; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

9.  Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15,183 recipients.

Authors:  A C Webster; J C Craig; J M Simpson; M P Jones; J R Chapman
Journal:  Am J Transplant       Date:  2007-07-19       Impact factor: 8.086

10.  Spectrum of cancer risk among US solid organ transplant recipients.

Authors:  Eric A Engels; Ruth M Pfeiffer; Joseph F Fraumeni; Bertram L Kasiske; Ajay K Israni; Jon J Snyder; Robert A Wolfe; Nathan P Goodrich; A Rana Bayakly; Christina A Clarke; Glenn Copeland; Jack L Finch; Mary Lou Fleissner; Marc T Goodman; Amy Kahn; Lori Koch; Charles F Lynch; Margaret M Madeleine; Karen Pawlish; Chandrika Rao; Melanie A Williams; David Castenson; Michael Curry; Ruth Parsons; Gregory Fant; Monica Lin
Journal:  JAMA       Date:  2011-11-02       Impact factor: 157.335
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.